Company / Goodwill
Johnson & Johnson Goodwill History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Goodwill
$48.8B
FY2025
5-year range
$25.4B / $48.8B
FY2021-FY2025
Trend
+10.3%
vs FY2024
Sector context
#2 of 73
Health Care
What the data says
Among 73 Health Care companies, Johnson & Johnson is in the top 3% for goodwill. Goodwill has increased for 4 consecutive years, from $25.4B in FY2021 to $48.8B in FY2025.
Based on SEC 10-K filings.
$48.8B in FY2025 with a 5-year CAGR of +6.0%. Ranks 2nd among 73 companies in Health Care.
Improved from $36.6B to $48.8B over the past 2 years.
Health Care sector context is included.
Goodwill over time
Growth rates
- 3-Year CAGR
- +10.6%
- 5-Year CAGR
- +6.0%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 73This company $48.8B Sector average $4.1B
▼
+1097.9% above sector average
Key checks
Key Insights
- Johnson & Johnson's goodwill has grown for 4 consecutive years.
- 5-year CAGR of +6.0%, indicating consistent growth.
- In FY2025, goodwill increased 10.3% year-over-year.
- Ranks #2 out of 73 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 27.3%
- Strong return on equity: 31.7%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | GoodwillValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $48.8B | +10.3% |
| FY2024 | $44.2B | +20.9% |
| FY2023 | $36.6B | +1.4% |
| FY2022 | $36.0B | +41.7% |
| FY2021 | $25.4B | -30.1% |
| FY2020 | $36.4B | +8.2% |
| FY2019 | $33.6B | +10.5% |
| FY2018 | $30.5B | -4.6% |
| FY2017 | $31.9B | +39.9% |
| FY2016 | $22.8B | +5.4% |
As of FY2025 · SEC 10-K · Updated Mar 11, 2026